GLP-1 Adherence Eclipses Affordability as Top Adoption Hurdle, Kamath Claims

Unattributed assertion shifts weight-loss injection narrative from access/cost to long-term compliance — no data cited, but signals opportunity for behavioral and retention-focused solutions.

bt-corporate · 6/28/2026, 3:33:29 PM · Ask about this →